eRapport

Hepa-Navi: Planning and Navigation System for Liver Resections

Prosjekt
Prosjektnummer
2014117
Ansvarlig person
Ole Jakob Elle
Institusjon
Oslo universitetssykehus HF
Prosjektkategori
Postdoktorstipend
Helsekategori
Cancer, Oral and Gastrointestinal
Forskningsaktivitet
4. Detection and Diagnosis, 5. Treatment Developement
Rapporter
2019 - sluttrapport
“Hepa-Navi: Planning and Navigation System for Liver Resections” project was initially to hire both a PostDoc and a clinical PhD. But, due to initial funding limitations, only a Postdoc was hired that led to some changes in the initial objectives. However, the major objective of Hepa-Navi project, i.e. to provide a complete planning and navigation system, always remained. Hepa-Navi’s initial objectives with both PostDoc and PhD: O1) Novel MR protocols for better visualization of liver anatomy O2) Clinician friendly system for segmentation of liver, blood vessels and tumor O3) Integration of laparoscopic navigated ultrasound and Intra-operative model update using ultrasound. O4) Clinical evaluation and validation of tools The PostDoc hired through the project started by implementing a user-friendly liver blood vessel segmentation method by creating a module in the 3D-Slicer. Later, also helped in integration of liver resection planning software into the 3D Slicer, which led to the development of the first version of Hepa-Navi Planning. With the NORMIT project (normit.no), the system was later made as NORMIT-plan, making it a national level planning system for liver resections. Since the automatic segmentation of different regions was more complicated enough to be PhD topics by itself, through the EU project HiPerNav (coordinated by Ole Jakob Elle), the PostDoc supervised and collaborated with multiple PhDs for these tasks. The PostDoc is, through the HiPerNav project, the main technical supervisor for Pravda, working on deep learning based automatic liver parenchyma segmentation; and co-supervisor to Shanmugapriya, working on deep learning based automatic segmentation of liver blood vessels. Also, the PostDoc is the main supervisor to Yuliia, funded by the Akkuttklinikkan through project proposal by the PostDoc himself, working on automatic tumor segmentation, classification and early prediction algorithm. All these works were part of objective O2. Due to the lack of a clinical PhD funded through this project, the objective O1 was rethought as providing a good visualization tool for liver anatomy. This was made possible with introduction of mixed reality system, Microsoft HoloLens, where physical and digital objects co-exist and interact in real time providing better 3D depth information to the surgeons. Through projects HoloViz and HoloNav, innovation projects led by the PostDoc and funded by Helse Sør Øst, Postdoc continued to work on providing the complete planning and navigation system in the HoloLens. The resection planning from NORMIT-plan was reimplemented for HoloLens. The HoloLens projects were in industrial collaboration with SopraSteria that provided the development behind the apps. Building a navigation system as per the objective O3 was not realized, as it relied on a prototype of laparoscopic navigation ultrasound to be provided from Trondhiem that was yet not provided. Thus, the objective was made as a task of having a general navigation system for laparoscopic liver resection. Through the HoloNav project, the Postdoc worked to provide a navigation system for liver surgery with the use of Polaris tracking systems and HoloLens. Since liver is soft tissue making it difficult for navigation tasks, the PostDoc worked with another Innovation project OrthoNav where the same technology was used for orthopedic navigation. This system was tested on patients as a diagnostic tool to provide X-ray vision to the clinicians to dynamically view the movement of bones within the body. Further, the Postdoc also collaborated with Andrea, PhD from HiPerNav working on liver navigation, in understanding the need of intraoperative imaging for use of navigation for laparoscopic liver surgery. For the objective O4, the Postdoc worked closely with clinical Postdoc Henrik and clinical PhD Egidijus(HiPerNav) on clinically evaluating the effect of the use of mixed reality for clinical purposes for both liver and congenital heart use. Primary liver cancer, which consists predominantly of Hepatocellular Carcinoma (HCC), is the fifth most common cancer worldwide and the third most common cause of cancer mortality. The incidence of primary liver cancer is increasing in several developed countries and expected to continue increasing. The liver is also a frequent target of metastases from other cancer origins, like colorectal, with an estimated 550,000 cases per year. In Norway, the most frequent liver neoplasms evaluated for surgical treatment are colorectal metastases. Liver resection is also the treatment of choice with hepatic colorectal metastases, even in recurrent cases. Surgical resection of malignant liver tumors is the only curative therapy. The introduction of laparoscopic liver resection is also changing many aspects of liver surgery, not least for the patients. However, operating laparoscopically on a solid organ as the liver is very demanding, and necessitates meticulous studies of the patient’s anatomy in order to preoperatively create a safe plan for the operation. Thus, planning is an integral part of laparoscopic resection workflow, where the surgeons decide beforehand on the resection plan for the surgery. 3D visualisation of liver anatomy with interactive tracing of instruments, i.e. navigation, will be a giant leap forward for laparoscopic liver surgery. The Hepa-Navi project had worked diligently in solving many of the bottlenecks in providing a complete planning and navigation system for laparoscopic liver surgery. The results from O1 has resulted in direct use of mixed reality visualisation for regularly at MDT meetings, and liver and heart surgery planning at the OUS-Rikshospitalet. Also, results from O2 will help in providing a fast automatic segmentation of organs which will help in fast visualisation of medical images in 3D. Thereby, increasing the possibility of using intraoperative imaging and navigation for surgeries. Finally, the results from O3 will help in providing navigation tool that could be used during surgery to easily locate the tumor in livers for laparoscopic liver resection surgery. The project led to multiple successful proposal fundings, such as 1 EU project - HiPerNav (16 PhDs, 2016), 2 Helse Sør-Øst innovation projects (HoloViz-2016 & HoloNav-2017), one Akkuttklikkan OUS PhD funding (2018), 1 Forskningsrådet BIA funding (75million NOK, 2019). Being the first to work on mixed reality for medicine in Norway, we were first featured in the NRK’s news segment. We also received the Microsoft Global Health Innovation Award 2017, and later, won the Computer World's eHelsePrisen 2017 and second prize for the Inven2 IdePrisen 2017. We also got a lot of attention over the years from many media sources. The HoloViz project lead by the Postdoc was proudly selected as one in 18 projects from whole of Norway to be in report for Norwegian Ministry of Health on research and innovation for patient’s best. The Postdoc has also resulted in submission of multiple DOFIs, which were taken under a single umbrella of DOFIs. These DOFIs led to the founding of a unique med-tech company HoloCare AS, with public-private partnership between Inven2 representing OUS, and SopraSteria. HoloCare AS aims provide clinicians with solutions that support them in reducing risk in operations. The formation of HoloCare AS guarantees better and faster use of results from HepaNavi project into daily clinical routines in Norway and around the world.

NO

2018
The Hepa-Navi project aims to provide a complete planning and navigation system for liver resections. In the past year, we are have provided liver resection planning platform in mixed reality (HoloLens) and have also started working on providing a navigation platform in the mixed reality that could be taken in to surgery.In Norway, the most frequent liver neoplasms evaluated for surgical treatment are colorectal metastases. Liver resection is the treatment of choice for hepatic colorectal metastases, even in recurrent cases. Surgical resection of malignant liver tumors is the only curative therapy. The introduction of laparoscopic liver resection is also changing many aspects of liver surgery, not least for the patients. However, operating laparoscopically on a solid organ as the liver is very demanding, and necessitates meticulous studies of the patient’s anatomy in order to preoperatively create a safe plan for the operation. Thus, planning is an integral part of laparoscopic resection workflow, where the surgeons decide beforehand on the resection plan for the surgery. 3D visualization of liver anatomy with interactive tracing of instruments, i.e. navigation, would be a giant leap forward for laparoscopic liver surgery. The main objective of “Hepa-Navi: Planning and Navigation System for Liver Resections” is to provide a complete planning and navigation system. Over the years, we have developed planning software platform as an extension in 3DSlicer, where the surgeons can manipulate a resection plane placed within a 3D model of the liver containing the blood vessel and tumor(s). By manipulating the resection plane, as they would imagine making the surgical cut, the surgeons can better plan the surgery. The project also led to multiple successful proposal funding, such as 1 EU project - HiPerNav (16 PhDs, 2016), 2 Helse Sør-Øst innovation projects (2016 & 2017), one Akkuttklikkan OUS funding (1 PhD, 2018), 1 Forskningsrådet BIA funding (75million NOK, 2019). The HiPerNav project aims to solve the bottlenecks in soft tissue navigation for surgery. As part of the project, the Hepa-Navi postdoc is supervising two PhDs working on deep learning methods for automatic liver, lesions and blood vessel segmentation. The postdoc is also the project leader for the two-innovation funding (HoloViz and HoloNav). Through HoloViz (completed), we achieved in bringing a complete planning system for both liver and heart surgery to mixed reality HoloLens device. It gives the surgeons the ability to use the planning system during surgery as the interaction are done in air, making it sterile compatible. All work done in the related projects by the postdoc are in direct line with the HepaNavi project. In the year 2018, the HoloViz project lead by the postdoc was selected as one in 18 projects from whole of Norway to be in report for Norwegian Ministry of Health on research and innovation for patient’s best. In the HoloNav (on-going) project, we have achieved an initial version of tracking tools in mixed reality by combination of Polaris system and HoloLens. An abstract on the successful testing was accepted in ISBI conference 2019, which will be later expanded for a journal paper. During 2019 the results will be tested further, initially in animal studies and later in surgery. The postdoc has also successfully got PhD proposal funded by the Akkuttklinkan, where the PhD (posdoc being the main supervisor) will be working on deep learning methods for automatic liver lesion classification and development of an early detection system for liver cancer. The postdoc was also involved in the successful Forskningsrådet BIA proposal with 75million project budget, which aims to work on AI for automatic segmentations, building the cloud solution and its final clinical studies.

No

2017
The Hepa-Navi project aims to provide a complete planning and navigation system for liver resections. To bring the latest cutting edge mixed reality (MR) technology into surgery, we have opened the project to include development and clinical validation of planning and navigation systems with use of Microsoft HoloLens.Surgical resection of malignant liver tumors is the only curative therapy. Planning is an integral part of laparoscopic resection workflow, where the surgeons decide beforehand on the resection plan for the surgery. Earlier, surgeons mentally planned the resection by looking at the CT/MRI images, thus making it difficult to discuss their plans with other surgeons. With development of our Hepa-Navi platform for planning liver resections on a computer using segmented and then 3D generated models, the surgeons can plan better and safer resections. However, visualization of 3D anatomical structures on a flat screen may only partially improve spatial understanding, which is not sufficient in complex cases. Thus MR 3D visualization, which is the merging of real and virtual worlds where physical and digital objects co-exist and interact in real time, could provide better 3D information to the surgeons. The earlier Hepa-Navi platform has now been taken further with integration of methods into MR as part of modified WP4, giving the surgeons a better spatial and depth information. Also, with the use of multiple HoloLens, multiple surgeons can now discuss on the same 3D liver model and plan the resection together. As part of the WP5, the system is currently tested during surgery and we are collecting valuable evaluation. An early assessment on use during 3 surgeries show that our application is highly recommendable and relatively comfortable for use. More evaluations are being performed for more in-depth evaluation, which will be published soon. We are also working to track the instruments in the model and automatic placement of the model according to the patient, as part of navigation for better use during the surgery. The development for MR was accelerated with two successful innovation fundings, HoloViz(completed) and HoloNAV(ongoing), where the postdoctoral researcher associated with Hepa-Navi is the project leader for both the innovation projects. Being the first group to work on MR for medicine in Norway, we were first featured in the NRK’s news segment. In February 2017, we received the Microsoft Global Health Innovation Award 2017. Later, we also won the Computer World's eHelsePrisen 2017 and second prize for the Inven2 IdePrisen 2017. We also got a lot of attention from many media sources. Though there had been slight change from the initial project work-packages and timeline, the changes are still in-line with the main goal of providing a complete planning and navigation system. With the change, we have managed to bring latest visualisation technologies into surgery. The results from the Hepa-Navi project had helped in receiving funding from the EU Marie Sklodowska-Curie actions for the project HiPerNav (High Performance soft-tissue Navigation), where Ole Jakob Elle (project leader of Hepa-Navi) is the project coordinator. Under HiPerNav, the postdoc of Hepa-Navi is co-main supervisor to one PhD working on segmentation of liver with deep learning(WP2), co-supervisor to one PhD working on segmentation of liver blood vessels with deep leaning(WP2), and collaborating with 2 other PhDs, where one will be working on clinical validation of methods (WP5) and other on developing navigation solutions (WP3). Apart from the above mentions tasks, the postdoc is also working on WP2 for creating a liver segment classification system and a generalised liver blood vessel segmentation method thats works on CT and MRI of varying resolution.

NO

2016
The Hepa-Navi project will provide a complete planning platform for liver resections. The platform has currently been integrated with user-friendly blood vessel segmentation for Liver. The method has been now completely adapted for CT images, with added ability for the user to select and merge overlapped regions as either hepatic or portal.The main objective of “Hepa-Navi: Planning and Navigation System for Liver Resections” is to provide a complete planning and navigation system. Hepa-Navi is developed at The Intervention Centre, Oslo University Hospital. The platform already has resection planning, where the surgeons can manipulate a resection plane placed within a 3D model of the liver containing the blood vessel and tumor(s). By manipulating the resection plane, as they would imagine making the surgical cut, the surgeons can better plan the surgery. Also, the resection planning part of Hepa-Navi has been clinically tested. Before the start of this post-doctoral research project, the segmentation and visualizations of the blood vessels and liver were performed externally to the platform. Now the surgeons have the opportunity to segment blood vessels and the liver from CT abdominal images within the software platform. The new blood vessel segmentation method used in the platform is a liver specific adaptation of our previously published method for general blood vessel segmentation using CT/MR angiogram images. Compared to blood vessel segmentation in these angiogram images, segmentation using CT abdominal images is more complicated as the images are very noisy and vessel overlaps are also high. Thus a preprocessing step was developed to specifically enhance the CT images for vessel segmentation; additionally the algorithm was improved to detect more complex bifurcations present in liver anatomy. Also, a tool is provided to the user for selecting the overlapped regions segmented as both hepatic and portal, so they can be relabeled as either hepatic or portal. In 2017, this part of the project will focus on extending the algorithm to also work on MR images and to evaluate the current algorithm clinically. The current platform also has a liver segmentation module, in which the clinicians can semi-automatically segment liver and tumor. Here, the user interactions are limited to drawing an initial approximate contour on one of the slices, and the algorithm then detects the corresponding liver border for all the other slices. The module also gives the user the option to make final corrections to the segmentation in 2D. A software developer under the supervision of the post-doctoral fellow performed this part of the project. In 2017, the focus for this part of the project will towards developing a nearly automatic segmentation method for liver and tumor, and also to provide liver classification into anatomical segments with use of the blood vessel segmentation. The results from the Hepa-Navi project have helped in receiving funding from the EU Marie Sklodowska-Curie actions for the project HiPerNav (High Performance soft-tissue Navigation). Ole Jakob Elle at the Intervention Centre, Oslo University Hospital is coordinating the HiPerNav project, which has 16 young researchers divided between 10 different European research institutions and companies. 3 PhDs (2 technical and 1 clinical) under HiPerNav will be starting early 2017 at the Intervention Centre, the post-doctoral fellow of Hepa-Navi will be supervising and collaborating with these students. Here, the technical PhDs will be researching liver segmentation tasks and laparoscopic liver navigation. The clinical PhD will be working on clinical evaluation of the Hepa-Navi platform. The post-doctoral fellow funded by the HepaNavi project was on paternity leave from August 2015 to April 2016.
2015
Hepa-Navi prosjektet har som mål å utvikle et komplett planleggings- og navigasjonsverktøy for leverreseksjoner. Plattformen har nå (I rapporteringsperioden) blitt utvidet med en rask og brukervennlig metode for å trekke ut blodårestrukturen i leveren (segmentering) og visualisere denne for kirurgen i 3D.Leverreseksjon krever nøyaktig individuell planlegging av kirurgisk strategi, spesielt ved bruk av ikke-anatomisk vevssparende teknikker. En optimal reseksjonslinje er viktig for å oppnå en adekvat og sikker reseksjonsmargin og beskytte de store lever- og portvenene for å redusere blødning under reseksjon av levervevet og også sikre blodstrøm inn og ut av den gjenværende del av lever. Hovedformålet med prosjektet er å frembringe en komplett planleggings- og navigasjonsplattform med innebyggede segmenterings- og visualiserings metoder (Hepa-Navi). Vår første versjon av Hepa-Navi har blitt klinisk testet. I denne versjonen ble blodårer, lever og kreftsvulst segmentert fra bildematerialet utenfor Hepa-Navi systemet for senere å bli importert tilbake til systemet som et anatomisk kart i 3D. I gjeldende system, “Hepa-Navi: Planning and Navigation System for Liver Resections” finansiert gjennom Helse Sør-Øst, har vi implementert og er i avslutningsfasen av å integrere i plattformen en rask og brukervennlig metode for segmentering av blodårestrukturen i lever. Dette vil hjelpe brukerne (klinikerene) til å trekke ut blodårestrukturen direkte fra CT bildene uten ekstern hjelp og bruk av annen programvare. Metoden baserer seg på en publisert generell metode utviklet gjennom doktorgradsarbeidet til postdok Rahul Kumar, hvor brukeren plasserer et «seed-point» i starten av blodåren som ønskes segmentert og ett nytt «seed-point» som indikerer retningen som segmenteringen skal følge gjennom blodårestrukturen. Denne prosessen må så følges for alle brodårene i leveren som ønskes segmentert. All segmenterings- og planleggingsprogramvare til bruk I Hepa-Navi plattformen er integrert I open-source 3D Slicer (www.slicer.org). Gjennom det grafiske brukergrensesnittet (GUI) for blodåresegmenteringsalgoritmen, får brukeren beskjed om å plassere et start-punkt (seed-point) og et punkt lenger ut I den blodåren som ønskes segmentert for å indikere retning. Resultatet av segmenteringen er så automatisk modellert og visualisert i 3D for å bedre forståelsen av den gjeldende blodårestrukturen. Hoveddeltakerene i prosjektet er post-doktoren som er finansiert gjennom denne Helse Sør-Øst finansieringen, Rahul Kumar, kirurg Bjørn Edwin og prosjektleder Ole Jakob Elle. Rahul Kumar, har fått innvilget av Helse Sør-Øst utsettelse av prosjektet grunnet hans pappapermisjon fra August 2015 til April 2016.
2014
Hepa-Navi project is envisioned to be a complete planning and navigation system for liver resections. The main challenges to be addressed here are integration of blood vessel segmentation, automatic segmentation of liver segments and integration of ultrasound data into platform.Primær kreft i lever er den femte mest vanlige kreftformen i verden, og den tredje største årsaken til dødsfall relatert til kreft. Kreft i leveren oppstår også gjerne som spredning fra andre primære kreftformer, så som fra kreft i tykktarm. Det oppstår omtrent 550.000 nye tilfeller av spredning til leveren per år på verdensbasis. Leverreseksjon er det primære valg av behandlingsstrategi for denne kreftformen, med en 5 års overlevelse på opptil 40-58% etter reseksjon. Nøyaktig og rask 3D visualisering av blodårene er viktig ved lever reseksjon. Leverreseksjon kan utføres som "formell reseksjon" eller "parenchymasparende teknikk". Ved parenchyma-sparende teknikk utførers reseksjonen slik at kun området rundt kreftsvulsten fjærnes i motsetning til den formelle reseksjon hvor den anatomiske halvdel som inneholder kreft blir fjernet. På denne måten spares mye levervev, som igjen gjør det mulig å operere pasienten flere ganger hvis kreften kommer tilbake. Denne levervevsssparende teknikk krever grundig planlegging av strategi i hvert individuelle tilfelle. Nøyaktig visualisering av leveren og dennes strukturer inkludert relevandte blodårestrukturer og tumorenes plassering er viktig informasjon under slik planlegging. Siden prosjektets start i desember 2014, prosjektets første måned, har det påløpt arbeid med integrering av en ny metode for ekstrahering av blodårestrukturen til leveren inn i en programvareplattform for levernavigasjon, Hepa-Navi. Dette er en metode utviklet ved Intervensjonssenteret ved Oslo Universitetssykehus. Metoden vil gi kirurgene en unik mulighet til å lage en rask modell av blodårestrukturen direkte fra CT/MR bilder ved å definere noen enkle startpunkter i bildene. Metoden er såpass rask at det skal kunne lages nye modeller underveis i operasjonen ved nye opptak av bildedata, slik at endringer skal kunne oppdateres. på denne måten vil "kart og terreng" stemme bedre overens under navigasjon.
Vitenskapelige artikler
Pelanis E, Kumar RP, Aghayan DL, Palomar R, Fretland ÅA, Brun H, Elle OJ, Edwin B

Use of mixed reality for improved spatial understanding of liver anatomy.

Minim Invasive Ther Allied Technol 2020 Jun;29(3):154-160. Epub 2019 mai 22

PMID: 31116053

Teatini A, Pelanis E, Aghayan DL, Kumar RP, Palomar R, Fretland ÅA, Edwin B, Elle OJ

The effect of intraoperative imaging on surgical navigation for laparoscopic liver resection surgery.

Sci Rep 2019 Dec 10;9(1):18687. Epub 2019 des 10

PMID: 31822701

Luzon JA, Kumar RP, Stimec BV, Elle OJ, Bakka AO, Edwin B, Ignjatovic D

Semi-automated vs. manual 3D reconstruction of central mesenteric vascular models: the surgeon's verdict.

Surg Endosc 2020 Nov;34(11):4890-4900. Epub 2019 nov 19

PMID: 31745632

Brun H, Bugge RAB, Suther LKR, Birkeland S, Kumar R, Pelanis E, Elle OJ

Mixed reality holograms for heart surgery planning: first user experience in congenital heart disease.

Eur Heart J Cardiovasc Imaging 2019 Aug 01;20(8):883-888.

PMID: 30534951

Kumar RP, et. al.

Use of mixed reality for surgery planning: assessment and development workflow

Nature: Scientific Reports, Submitted

Teatini A, Kumar RP, Wiig O, Elle OJ

Mixed Reality as a novel tool for diagnostic and surgical navigation in orthopaedics

IJCARS, Submitted

Pelanis E, Kumar RP, Fretland ÅA, Elle OJ, Edwin B

An early assessment for the use of HoloLens during laparoscopic liver resections

HPB, 2018/9/1, 20, S239

Deltagere
  • Henrik Brun Postdoktorstipendiat (annen finansiering)
  • Yuliia Kamkova Doktorgradsstipendiat (annen finansiering)
  • Shanmugapriya Survarachak Doktorgradsstipendiat (annen finansiering)
  • Pravda Jith Ray Prasad Doktorgradsstipendiat (annen finansiering)
  • Andrea Teatini Doktorgradsstipendiat (annen finansiering)
  • Egidijus Pelanis Doktorgradsstipendiat (annen finansiering)
  • Bjørn Edwin Medveileder
  • Ole Jakob Elle Prosjektleder
  • Rahul Prasanna Kumar Postdoktorstipendiat (finansiert av denne bevilgning)

eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT

Alle henvendelser rettes til eRapport

Personvern  -  Informasjonskapsler